Terms: = Pancreatic cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Treatment
27 results:
1. Surgical treatment for pancreatic cystic lesions-implications from the multi-center and prospective German StuDoQ|Pancreas registry.
Henn J; Wyzlic PK; Esposito I; Semaan A; Branchi V; Klinger C; Buhr HJ; Wellner UF; Keck T; Lingohr P; Glowka TR; Manekeller S; Kalff JC; Matthaei H;
Langenbecks Arch Surg; 2023 Jan; 408(1):28. PubMed ID: 36640188
[TBL] [Abstract] [Full Text] [Related]
2. PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated vegfr3 dephosphorylation.
Chang TM; Chu PY; Lin HY; Huang KW; Hung WC; Shan YS; Chen LT; Tsai HJ
J Biomed Sci; 2022 Nov; 29(1):92. PubMed ID: 36336681
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of Society Guidelines for the Management and Surveillance of pancreatic Cysts: A Review.
Aziz H; Acher AW; Krishna SG; Cloyd JM; Pawlik TM
JAMA Surg; 2022 Aug; 157(8):723-730. PubMed ID: 35731507
[TBL] [Abstract] [Full Text] [Related]
4. The role of intraperitoneal chemotherapy in the surgical management of pancreatic ductal adenocarcinoma: a systematic review.
Brind'Amour A; Webb M; Parapini M; Sidéris L; Segedi M; Chung SW; Chartier-Plante S; Dubé P; Scudamore CH; Kim PTW
Clin Exp Metastasis; 2021 Apr; 38(2):187-196. PubMed ID: 33486670
[TBL] [Abstract] [Full Text] [Related]
5. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration.
Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S
Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182
[TBL] [Abstract] [Full Text] [Related]
6. Kinome Array Profiling of Patient-Derived pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases.
Creeden JF; Alganem K; Imami AS; Brunicardi FC; Liu SH; Shukla R; Tomar T; Naji F; McCullumsmith RE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213062
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic performance of current guidelines and postoperative outcome following surgical treatment of cystic pancreatic lesions - a 10-year single center experience.
Kovacevic B; Hansen MC; Kristensen TS; Karstensen JG; Klausen P; Storkholm J; Hansen CP; Vilmann P
Scand J Gastroenterol; 2020 Dec; 55(12):1447-1453. PubMed ID: 33147090
[TBL] [Abstract] [Full Text] [Related]
8. Co-delivery of gemcitabine prodrug along with anti NF-κB siRNA by tri-layer micelles can increase cytotoxicity, uptake and accumulation of the system in the cancers.
Norouzi P; Amini M; Dinarvand R; Arefian E; Seyedjafari E; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111161. PubMed ID: 32806226
[TBL] [Abstract] [Full Text] [Related]
9. Dendritic Polyglycerol-Derived Nano-Architectures as Delivery Platforms of Gemcitabine for pancreatic cancer.
Ray P; Ferraro M; Haag R; Quadir M
Macromol Biosci; 2019 Jul; 19(7):e1900073. PubMed ID: 31183964
[TBL] [Abstract] [Full Text] [Related]
10. Timing and Clinical Features of Spontaneous Decrease in Size of Small pancreatic Cystic Lesions without High-Risk Stigmata.
Lee HW; Lee SK; Jun JH; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
Gut Liver; 2020 Mar; 14(2):248-256. PubMed ID: 31060116
[TBL] [Abstract] [Full Text] [Related]
11. Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling.
Yang D; Tang Y; Fu H; Xu J; Hu Z; Zhang Y; Cai Q
Biochem Biophys Res Commun; 2018 Oct; 505(1):215-221. PubMed ID: 30243721
[TBL] [Abstract] [Full Text] [Related]
12. Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast cancer.
Zhao EY; Shen Y; Pleasance E; Kasaian K; Leelakumari S; Jones M; Bose P; Ch'ng C; Reisle C; Eirew P; Corbett R; Mungall KL; Thiessen N; Ma Y; Schein JE; Mungall AJ; Zhao Y; Moore RA; Den Brok W; Wilson S; Villa D; Shenkier T; Lohrisch C; Chia S; Yip S; Gelmon K; Lim H; Renouf D; Sun S; Schrader KA; Young S; Bosdet I; Karsan A; Laskin J; Marra MA; Jones SJM
Clin Cancer Res; 2017 Dec; 23(24):7521-7530. PubMed ID: 29246904
[No Abstract] [Full Text] [Related]
13. GDC-0449 improves the antitumor activity of nano-doxorubicin in pancreatic cancer in a fibroblast-enriched microenvironment.
Zhou Q; Zhou Y; Liu X; Shen Y
Sci Rep; 2017 Oct; 7(1):13379. PubMed ID: 29042665
[TBL] [Abstract] [Full Text] [Related]
14. Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery?
Puri PM; Watkins AA; Kent TS; Maggino L; Jeganathan JG; Callery MP; Drebin JA; Vollmer CM
J Gastrointest Surg; 2018 Jan; 22(1):88-97. PubMed ID: 28875275
[TBL] [Abstract] [Full Text] [Related]
15. [Minimally invasive and robot-assisted surgery for pancreatic cystic tumors].
Welsch T; Distler M; Weitz J
Chirurg; 2017 Nov; 88(11):934-943. PubMed ID: 28842736
[TBL] [Abstract] [Full Text] [Related]
16. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated January 2017.
Dumonceau JM; Deprez PH; Jenssen C; Iglesias-Garcia J; Larghi A; Vanbiervliet G; Aithal GP; Arcidiacono PG; Bastos P; Carrara S; Czakó L; Fernández-Esparrach G; Fockens P; Ginès À; Havre RF; Hassan C; Vilmann P; van Hooft JE; Polkowski M
Endoscopy; 2017 Jul; 49(7):695-714. PubMed ID: 28511234
[TBL] [Abstract] [Full Text] [Related]
17. Management of patients with pancreatic cystic lesions: A case-based survey.
Müssle B; Distler M; Wolk S; Shrikhande SV; Aust DE; Arlt A; Weitz J; Hackert T; Welsch T
Pancreatology; 2017; 17(3):431-437. PubMed ID: 28456590
[TBL] [Abstract] [Full Text] [Related]
18. Repositioning approved drugs for the treatment of problematic cancers using a screening approach.
Varbanov HP; Kuttler F; Banfi D; Turcatti G; Dyson PJ
PLoS One; 2017; 12(2):e0171052. PubMed ID: 28166232
[TBL] [Abstract] [Full Text] [Related]
19. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis.
Liu L; Zhi Q; Shen M; Gong FR; Zhou BP; Lian L; Shen B; Chen K; Duan W; Wu MY; Tao M; Li W
Oncotarget; 2016 Jul; 7(30):47145-47162. PubMed ID: 27323403
[TBL] [Abstract] [Full Text] [Related]
20. Melatonin Regulates Angiogenic Factors under Hypoxia in Breast cancer Cell Lines.
Jardim-Perassi BV; Lourenço MR; Doho GM; Grígolo IH; Gelaleti GB; Ferreira LC; Borin TF; Moschetta MG; Pires de Campos Zuccari DA
Anticancer Agents Med Chem; 2016; 16(3):347-58. PubMed ID: 25963143
[TBL] [Abstract] [Full Text] [Related]
[Next]
